Results for "consumer data right"
711-720 of 844 results for 'consumer data right'
Life insurance industry gets a remuneration Bill, ASIC report and Code of Practice
This is a significant week for the life insurance industry with the re-introduction by the Federal Government of a Bill to reform commissions payable on life insurance policies the release by ASIC of findings of its review of life insurance claims and the launch yesterday by the Financial Services ...
Major proposed changes to FIRB regime
On 5 June 2020 the Federal Treasurer announced major proposed changes to Australia's FIRB regime to address national security risks and ensure greater compliance with FIRB approval conditions. ...
Reforms to strengthen and streamline the FIRB regime
On 1 May 2024, the Australian Treasurer announced reforms to the Foreign Investment Review Board (FIRB) framework, to make it stronger, more streamlined and more transparent. On the same day, the Government released an updated Foreign Investment Policy document, setting out the reforms. ...
Retirement income covenants (and egg metaphors)
The long-promised retirement income covenants are slated to come into effect on 1 July 2022. The proposed covenants are aimed at improving retirement outcomes, including by moving retirees away from a 'nest egg' mentality towards spending more in retirement – or 'hatching' the nest egg (to borrow the extended metaphor of APRA's Deputy Chair). ...
Portfolio Holdings Disclosure regulations: key aspects of the revised regime
The long-awaited Portfolio Holdings Disclosure (PHD) regulations were made on 11 November 2021, which will give superannuation trustees certainty about the manner in which portfolio holdings information needs to be disclosed to the public. ...
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...
Capacity Investment Scheme now open for business: will it solve the capacity conundrum?
The first standalone Capacity Investment Scheme (CIS) tender round is now well underway, with Stage A 'Project bids' submitted in February. While we wait to see the final form clean dispatchable CISA and to hear the results of the tender round, we consider the current state of play. ...
Allens视界– 新冠病毒（COVID-19）促使FIRB体制发生重大变化
2020年3月29日，澳大利亚联邦政府财政部长宣布对澳大利亚的外国投资审查批准（FIRB）体制进行重大修改，以应对由新型冠状病毒（COVID-19）爆发引起的风险。这些修改虽然是暂时的，但大幅度地扩展了需要获得FIRB批准的交易范围，并大大延长了FIRB申请的审查期限。 ...
Major overhaul of Australia's foreign investment laws: what's new?
The new package of legislation overhauling Australias foreign investment laws the first major revision in 40 years commenced on 1 December 2015 While many features of the previous regime have been retained and sometimes re-named there are also a number of significant changes Partners Jeremy Low ...
World first: Australia says ‘yes’ to AI inventors
The decision in Thaler v Commissioner of Patents [2021] FCA 879 is the first judicial determination in the world in favour of AI systems being named as inventors of a patent. The availability of patent protection for AI-generated inventions is a vexed and controversial issue. ...